Skip to main content
MUSTANG BIO, INC. logo

MUSTANG BIO, INC. — Investor Relations & Filings

Ticker · MBIO ISIN · US62818Q1040 LEI · 5493004W0VC1DPECQ779 US Manufacturing
Open in API
Filings indexed 399 across all filing types
Latest filing 2017-01-03 Capital/Financing Update
Country US United States of America
Listing US MBIO

About MUSTANG BIO, INC.

https://www.mustangbio.com/

Mustang Bio, Inc. is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel cell and gene therapies. The company's primary focus is on translating medical breakthroughs into potential cures for difficult-to-treat cancers and rare genetic diseases. Its pipeline is centered on Chimeric Antigen Receptor (CAR) T-cell therapies, a form of immunotherapy. Mustang Bio's strategy involves in-licensing promising technologies from academic institutions and advancing them through clinical trials, supported by its in-house manufacturing capabilities to ensure the production and delivery of these advanced treatments.

Recent filings

Filing Released Lang Actions
FORM 8-K
Capital/Financing Update Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The content describes a private placement financing transaction, including the sale of equity securities and related agreements, as well as the repayment of a promissory note. This fits the category of Capital/Financing Update (CAP) because it details fundraising activities and changes in capital structure. The document is not an annual or quarterly report, audit report, or earnings release, nor is it a proxy or voting result announcement. It is a regulatory filing but specifically focused on capital raising events, so CAP is the most appropriate classification. The document length and detail support a confident classification.
2017-01-03 English
FORM 8-K
Capital/Financing Update Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The content describes a private placement financing transaction, including details about the sale of units consisting of common stock and warrants, placement agent fees, and references to related agreements. There is no financial statement or comprehensive financial analysis present, nor is it an earnings release or annual/interim report. The document is clearly an update on a capital raising event, specifically a private placement of equity securities. Therefore, it fits the category of Capital/Financing Update (CAP). The document length is over 5,000 characters and contains substantive details about the financing transaction, supporting a high confidence level.
2016-12-16 English
Regulatory Filings 2016
Regulatory Filings
2016-12-13 English
FORM 8-K
Capital/Financing Update Classification · 100% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The content describes a private placement financing transaction, including details about the sale of units consisting of common stock and warrants, placement agent fees, and amendments to the placement agent agreement. This is clearly an update on the company's capital raising activities and financing arrangements. It is not an annual or quarterly report, audit report, earnings release, or any other type of report. The document is specifically about financing and capital structure changes. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length is sufficient and contains substantive details about the financing transaction, not just an announcement or reference to a report, so it is not RPA or RNS.
2016-12-06 English
FORM 10-Q
Interim / Quarterly Report 9M 2016
2016-11-14 English
Regulatory Filings 2016
Regulatory Filings
2016-11-04 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.